Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioDelivery Sciences International Inc (NASDAQ:BDSI)

2.30
Delayed Data
As of 4:00pm ET
 +0.05 / +2.22%
Today’s Change
1.50
Today|||52-Week Range
3.60
+31.43%
Year-to-Date
Endo (ENDP) Earnings & Revenues Beat in Q3, Generics Weak
Nov 10 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) to Report Q3 Earnings: What's in Store?
Nov 07 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q3 Earnings, Sales Beat Estimates
Nov 10 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.25
Today’s open2.25
Day’s range2.16 - 2.40
Volume546,272
Average volume (3 months)524,193
Market cap$125.7M
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-73.61%
Earnings growth (this year)+110.88%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-67.77%
P/E ratio25.6
Price/Sales6.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...-0.05-1.23%
ALRNAileron Therapeutics...-0.28-2.28%
ADMPAdamis Pharmaceutica...-0.15-3.57%
OCXOncoCyte Corp-0.10-2.27%
Data as of 4:10pm ET, 11/21/2017

Financials

Next reporting dateMarch 19, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$15.5M
Annual profit (last year)-$67.1M
Net profit margin-431.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Vice Chairman, President &
Chief Executive Officer
Mark A. Sirgo
CFO, Principal Accounting Officer &
Secretary
Ernest R. de Paolantonio
Corporate headquarters
Raleigh, North Carolina

Forecasts